Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata: a Clinical and Dermoscopic Study.

Alopecia areata is a condition that causes hair to fall out in small patches, and it can affect anyone, regardless of age or gender. This study aims to explore new treatments for this condition by comparing the effects of topical applications of Pentoxifylline and Metformin against the commonly used Betamethasone. These treatments are being tested because they have shown potential benefits in managing autoimmune responses, which are believed to be a key factor in alopecia areata. The goal is to find more effective ways to help people with alopecia areata regain hair and improve their quality of life, as the condition can severely impact self-esteem and social interactions. Participants in the study will apply topical forms of Pentoxifylline, Metformin, or Betamethasone to the affected areas of their scalp. The study will monitor changes in hair regrowth and evaluate any changes in the condition of the scalp. By measuring how well each of these treatments works, researchers hope to determine which treatment is most effective and has the fewest side effects. Since alopecia areata can cause significant emotional distress, identifying a better treatment option could provide much-needed relief for those affected.